TrialBreast cancer research and treatment2025

Impact of adding palbociclib on treatment adherence to ongoing adjuvant endocrine treatment in the global randomized PALLAS randomized trial in patients with early breast cancer.

Eileen Shinn et al.PubMed ↗Publisher ↗

No numbers read from the abstract.